Nucleic Acid Testing Market |Abbott Laboratories, Beckman Coulter, Inc., Becton
The market for nucleic acid testing (NAT) has grown thanks to its widespread use in molecular diagnostics. Nucleic acids have gained popularity as a useful molecular fingerprinting tool for identification. They have surpassed other modern technologies in the examination of microbial DNA in clinical samples because they are less time-consuming and offer quick findings. NAT has been employed to improve the efficacy of highly active antiretroviral therapy and antiretroviral (ARV) medicines for HIV in recent years. NAT is used to determine the viral load of HIV-1 RNA. Combining HIV-1 RNA viral load with nucleic acid sequence-based amplification is an example (NASBA).
For
amplifying RNA/DNA in vitro, polymerase chain reaction (PCR), and reverse
transcription-polymerase chain reaction (RT-PCR) have gained popularity. This
has aided in the growth of revenue in the NAT industry. The need for ligase
chain reaction is projected to skyrocket in the near future. Fast-growing
molecular diagnostic labs in many parts of the world provide a lot of drive.
The Nucleic Acid Testing market's competitive dynamics have been driven by a focus on molecular
testing's speed, specificity, and sensitivity.
The
advancements being achieved in molecular diagnostic labs are enhancing the NAT
market's application channel. The growing importance of NAT in oncology
research has piqued industry interest. To maintain their dominance in the NAT
industry, top players are focusing on continuous product development. They've
increased their spending on clinical pathways. The availability of robust
public research funding and the presence of robust healthcare system are
propelling the prospects in North America market. The regional market in Asia
Pacific is projected to receive new income.
Some of the
well-entrenched participants in the NAT market include Abbott Laboratories, Beckman Coulter, Inc.,
Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., F.
Hoffmann-La Roche Ltd., Grifols, S.A., Illumina, Inc., Novartis Ag, Qiagen
N.V., Quest Diagnostics Incorporated, Qiagen N.V., Quest Diagnostics
Incorporated, Quest Diagnostics

Comments
Post a Comment